RPS25 inhibitors (Discovery BioMed)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameRPS25 inhibitors (Discovery BioMed)
Drug Alias Nameribosomal protein S25 inhibitors (Discovery BioMed)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial Ribosomal Protein S25 inhibitors
TargetsMitochondrial Ribosomal Protein S25
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiscovery BioMed Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiscovery BioMed Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A